Breakdown |
---|
Income Statement |
Total Revenue |
Gross Profit |
EBITDA |
Net Income |
Balance Sheet |
Total Assets |
Cash, Cash Equivalents and Short-Term Investments |
Total Debt |
Total Liabilities |
Stockholders Equity |
Cash Flow |
Free Cash Flow |
Operating Cash Flow |
Investing Cash Flow |
Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $4.15B | 8.69 | 46.98% | ― | 12.54% | 25.47% | |
79 Outperform | $6.50B | 15.14 | 19.55% | ― | 8.38% | 52.18% | |
76 Outperform | $17.56B | 24.97 | 29.49% | 1.26% | 6.75% | 19.71% | |
75 Outperform | $16.10B | 42.55 | 76.24% | ― | 7.64% | 369.79% | |
71 Outperform | $8.61B | 10.06 | 29.16% | 2.86% | 1.07% | 28.03% | |
68 Neutral | $12.66B | 17.15 | 136.21% | 0.93% | 9.34% | 15.18% | |
64 Neutral | £1.72B | 10.45 | 6.12% | 3.16% | 0.58% | -32.48% |